Professor
Anesthesiology
Dr. Talmage Egan, MD
|
|
Give Review
Talmage Egan practices Anesthesiology. He attended University of Utah School of Medicine. Talmage Egan is a published MD. He published 61 publications, including: 'Apneic oxygenation associated with patient-controlled analgesia.' He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Using the entropy of tracheal sounds to detect apnea during sedation in healthy nonobese volunteers.
- An Exploration of Remifentanil-Propofol Combinations that Lead to a Loss of Response to Esophageal Instrumentation, a Loss of Responsiveness, and/or Onset of Intolerab...
- An evaluation of remifentanil-sevoflurane response surface models in patients emerging from anesthesia: model improvement using effect-site sevoflurane concentrations.
- Response surface model predictions of emergence and response to pain in the recovery room: An evaluation of patients emerging from an isoflurane and fentanyl anesthetic.
- Is anesthesiology going soft?: trends in fragile pharmacology.
- A tribute to Dr. Paul A. J. Janssen: entrepreneur extraordinaire, innovative scientist, and significant contributor to anesthesiology.
- An evaluation of remifentanil propofol response surfaces for loss of responsiveness, loss of response to surrogates of painful stimuli and laryngoscopy in patients und...
- When is a bispectral index of 60 too low?: Rational processed electroencephalographic targets are dependent on the sedative-opioid ratio.
- Prolonged apnea after remifentanil.
- Opioid-volatile anesthetic synergy: a response surface model with remifentanil and sevoflurane as prototypes.
- Preoperative "fentanyl challenge" as a tool to estimate postoperative opioid dosing in chronic opioid-consuming patients.
- Cyclodextrins as new formulation entities and therapeutic agents.
- Influence of hemorrhagic shock followed by crystalloid resuscitation on propofol: a pharmacokinetic and pharmacodynamic analysis.
- A response surface analysis of propofol-remifentanil pharmacodynamic interaction in volunteers.
- Attentional effects of noradrenaline vary with arousal level: selective activation of thalamic pulvinar in humans.
- Preoperative fentanyl infusion with pharmacokinetic simulation for anesthetic and perioperative management of an opioid-tolerant patient.
- Target-controlled drug delivery: progress toward an intravenous "vaporizer" and automated anesthetic administration.
- Target-controlled infusions for intravenous anesthetics: surfing USA not!
- The influence of hemorrhagic shock on propofol: a pharmacokinetic and pharmacodynamic analysis.
- A pharmacokinetic study to compare two simultaneous 400 microg doses with a single 800 microg dose of oral transmucosal fentanyl citrate.
- The pharmacokinetics and pharmacodynamics of propofol in a modified cyclodextrin formulation (Captisol) versus propofol in a lipid formulation (Diprivan): an electroen...
- The influence of hemorrhagic shock on etomidate: a pharmacokinetic and pharmacodynamic analysis.
- In vitro remifentanil metabolism: the effects of whole blood constituents and plasma butyrylcholinesterase.
- Decrease in bispectral index preceding intraoperative hemodynamic crisis: evidence of acute alteration of propofol pharmacokinetics.
- Midazolam and remifentanil by bolus injection for intensely stimulating procedures of brief duration: experience with awake laryngoscopy.
- Exploring the frontiers of propofol formulation strategy: is there life beyond the milky way?
- Stereochemistry and anesthetic pharmacology: joining hands with the medicinal chemists.
- Perioperative smoking cessation and anesthesia: a review.
- Acute compartment syndrome following a minor athletic injury.
- Remifentanil: an esterase-metabolized opioid.
- Asystole after anesthesia induction with a fentanyl, propofol, and succinylcholine sequence.
- An AIDS-associated cause of the difficult airway: supraglottic Kaposi's sarcoma.
- The successful implementation of pharmaceutical practice guidelines? Far from convincing!
- The use of remifentanil infusion to facilitate epidural catheter placement in a parturient: a case report with pharmacokinetic simulations.
- Predicting difficult laryngoscopy for tracheal intubation: an approach to airway assessment.
- Pharmacokinetic/dynamic assessment in drug development: application to the investigational opioid mirfentanil.
- Pharmacodynamic modeling of the electroencephalographic effects of flumazenil in healthy volunteers sedated with midazolam.
- The use of remifentanil for Cesarean section in a parturient with recurrent aortic coarctation.
- Apneic oxygenation associated with patient-controlled analgesia.
- Influence of arteriovenous sampling on remifentanil pharmacokinetics and pharmacodynamics.
- Pharmacokinetics and pharmacodynamics of remifentanil: an update in the year 2000.
- Remifentanil by bolus injection: a safety, pharmacokinetic, pharmacodynamic, and age effect investigation in human volunteers.
- Propofol dosing regimens for ICU sedation based upon an integrated pharmacokinetic-pharmacodynamic model.
- Remifentanil's effect is not prolonged in a patient with pseudocholinesterase deficiency.
- Remifentanil for conscious sedation and analgesia during awake fiberoptic tracheal intubation: a case report with pharmacokinetic simulations.
- Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development.
- Remifentanil versus alfentanil: comparative pharmacokinetics and pharmacodynamics in healthy adult male volunteers.
- Teaching sedation and analgesia with simulation.
- Remifentanil and propofol combination for awake craniotomy: case report with pharmacokinetic simulations.
- Influence of hemorrhagic shock on remifentanil: a pharmacokinetic and pharmacodynamic analysis.
- Multiple dose pharmacokinetics of oral transmucosal fentanyl citrate in healthy volunteers.
- The pharmacokinetics of the new short-acting opioid remifentanil (GI87084B) in healthy adult male volunteers.
- Remifentanil pharmacokinetics in obese versus lean patients.
- Dose proportionality and pharmacokinetics of oral transmucosal fentanyl citrate.
- The safety of remifentanil by bolus injection.
- Flow-through versus sidestream capnometry for detection of end tidal carbon dioxide in the sedated patient.
- Propofol in a modified cyclodextrin formulation: first human study of dose-response with emphasis on injection pain.
- Intravenous drug delivery systems: toward an intravenous "vaporizer".
- Remifentanil pharmacokinetics and pharmacodynamics. A preliminary appraisal.
- Fentanyl pharmacokinetics in hemorrhagic shock: a porcine model.
Schools
University Of Utah School Of Medicine
Stanford University Hospital
University Of Ut Med Center
Doctors Specialties
- Anesthesiology
Accepted Insurances
Education
-
Stanford University -
University of Utah -
University of Utah School of Medicine
Hospital
-
University of Utah Health Care - Hospital and Clinics
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1861582454 |
| Last Name Of The Provider | EGAN |
| First Name Of The Provider | TALMAGE |
| View All |
Similar Doctors
|
|
Dr. Joshua M. Zimmerman, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cris Cowley, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven I. Bott, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joshua O. Stream, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Philip N. Gnadinger, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeffrey K. Lu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Harold P. Sutherland, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Craig R. Jensen, MD |
|
|
Dr. Massimiliano Romanelli-Gobbi, MD |
|
|
Dr. Daniel P. Vezina, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Todd C. Seymour, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rachel Furman, MD |
|
|
Dr. Jeremy M. Harnden, MD
This Doctor is OpenDoctor Recommended.
|